3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
6
Metastatic Castration-resistant Prostate Cancer
2
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
1
Kidney Neoplasms
1
Glioma
1
Glioblastoma
1
Clear-cell metastatic renal cell carcinoma
1
Astrocytoma
1
Interventions
pembrolizumab
2
fludarabine
2
aldesleukin
2
Cyclophosphamide
2
cabozantinib
1
Specimen Handling
1
Radiosurgery
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Fulvestrant
1
Continuous Positive Airway Pressure
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urogenital Neoplasms
×
Pluvicto
×
30 days
×
Clear all
No trials found.